Profile
ACB ZTS TAK HLN TEVA ITCI
Company Name Aurora Cannabis Inc. Zoetis Inc. Takeda Pharmaceutical Company Limited Haleon plc Teva Pharmaceutical Industries Limited Intra-Cellular Therapies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $215.15M $73.16B $47.84B $46.83B $19.50B $14.05B
Employees 1.07K 13.80K 49.28K 24.56K 37.00K 0.86K
CEO Miguel Martin Ms. Kristin C. Peck Mr. Christophe Weber Mr. Brian James McNamara Richard D. Francis Dr. Sharon Mates Ph.D.
Ratings
ACB ZTS TAK HLN TEVA ITCI
Quant Rating Score 3 3 3 3 1 1
Quant Rating Neutral Neutral Neutral Neutral Strong Sell Strong Sell
Trading
ACB ZTS TAK HLN TEVA ITCI
Last Close $3.92 $157.23 $14.97 $10.5 $17 $131.87
High 52 $7.05 $196.48 $15.39 $11.41 $22.77 $131.91
Low 52 $3.46 $144.45 $12.89 $8.26 $12.82 $67.99
Price vs. 52 Week High -44.4 % -19.98 % -2.73 % -7.98 % -25.34 % -0.03 %
Price vs. 52 Week Low 13.29 % 8.85 % 16.14 % 27.12 % 32.61 % 93.95 %
Total Return
ACB ZTS TAK HLN TEVA ITCI
1 Month Return -28.73 % -3.29 % 2.75 % -5.75 % 0.24 % 0 %
3 Month Return -11.11 % -3.43 % -0.33 % 4.48 % 8.35 % 0.14 %
6 Month Return -9.68 % -5.01 % 13.93 % 7.8 % -24.85 % 53.34 %
9 Month Return -31.83 % -19.32 % 2.18 % -0.85 % -4.17 % 80.13 %
YTD Return -7.76 % -3.5 % 13.07 % 10.06 % -22.87 % 57.89 %
1 Year Return -17.3 % -8 % 15.87 % 23.53 % 4.62 % 85.5 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACB ZTS TAK HLN TEVA ITCI
Dividend Yield Percentage (TTM) - 1.13 % 4.52 % 0.01 % - -
Dividend Paid and Capex Coverage Ration (TTM) 0.85 % 2 % 1.65 % - 2.53 % -227.26 %
Dividend Per Share (TTM) - 1.86 % 196 % 0.05 % - -
Payout Ratio (TTM) - 32.25 % 280.28 % - - -
Growth
ACB ZTS TAK HLN TEVA ITCI
Asset Growth -9.46 % 0.76 % -9.55 % 87.69 %
Gross Profit Growth 304.26 % -0.19 % 5.47 % 44.88 %
Revenue Growth 15.86 % -0.61 % 4.4 % 46.62 %
Revenue 3 Year -63.56 % 19.01 % 1.52 % 556.51 %
Revenue 5 Year -82.8 % 33.95 % -5.5 % 600974.32 %
Revenue 10 Year - 33.95 % -38.45 % 32663.23 %
EBIT Growth - 13.52 % -169.63 % 26.77 %
Net Income Growth 73.87 % 37.46 % -193.2 % 46.54 %
Net Income 3 Yeari Growth Per Share 96.69 % 4.91 % -482.97 % 79.29 %
Net Income 5 Yeari Growth Per Share 96.31 % 122.63 % -58.26 % 72.95 %
Net Income 10 Yeari Growth Per Share 54.47 % 122.63 % -140.46 % 32.41 %
Operating Income Growth 81.73 % 10.52 % -169.98 % 26.77 %
Operating Cash Flow Growth (CFG) 40.85 % 9.57 % -8.85 % 41.08 %
Operating 3 Year CFG 89.24 % 71.6 % 52.26 % 77.79 %
Operating 5 Year CFG 94.43 % 196.04 % 123.59 % 69.4 %
Operating 10 Year CFG 81.37 % 196.04 % -81.66 % 10.87 %
EPS Growth 95.09 % 45.45 % -190 % 50.68 %
EPS Diluted Growth 95.09 % 45.45 % -190 % 50.68 %
Book Value Per Share -28.84 % -1.63 % -30.36 % 80.54 %
Share Holder 3 Year Equity Growth Per Share -90.92 % -37.97 % -49 % 116.52 %
Share Holder 5 Year Equity Growth Per Share -98.01 % -40.16 % -62.86 % 215.14 %
Share Holder 10 Year Equity Growth Per Share 8.57 % -40.16 % -82.6 % 164.65 %
Dividend Per Share Growth - 49.01 % - -
Dividend 3 Year Growth Per Share - -49.79 % - -
Dividend 5 Year Growth Per Share - -49.97 % -100 % -
Dividend 10 Year Growth Per Share - -49.97 % -100 % -
Debt Growth -53.94 % 6.83 % -10.29 % 0.25 %
Free Cash Flow Growth 33.21 % 16.27 % -11.05 % 40.95 %
Updated On 31 Mar 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
ACB ZTS TAK HLN TEVA ITCI
Gross Profit Margin TTM 54.65 % 70.2 % 54.7 % 61.52 % 49.17 % 91.63 %
Return on Assets TTM 0.19 % 17.86 % 0.76 % 4.2 % -3.35 % -5.46 %
Return on Equity TTM 0.28 % 51.32 % 1.48 % 8.73 % -21.38 % -7.4 %
Return on Capital Employed TTM 0.67 % 32.08 % 3.75 % 7.74 % 1.59 % -10.05 %
Net Income Per EBT TTM 7.81 % 78.79 % 61.12 % 75.5 % 246.36 % 100.64 %
EBT Per Ebit TTM 411.92 % 92.99 % 40.08 % 86.58 % -120.28 % 63.57 %
EBIT Per Revenue TTM 1.44 % 37.01 % 9.62 % 19.64 % 2.61 % -17.15 %
Cash Flow To Debt Ratio TTM 15.3 % 43.63 % 21.32 % - 7.47 % -430.93 %
Receivables Turnover TTM 8.08 6.82 6.32 5.9 4.91 4.09
Payables Turnover TTM 5.64 6.51 4.36 2.19 3.69 2.18
Inventory Turnover TTM 0.65 1.16 1.7 3.63 2.6 2.17
Fixed Asset Turnover TTM 128.04 % 253.65 % 232.78 % 584.75 % 332.7 % 4569.25 %
Asset Turnover TTM 40.26 % 65.87 % 32.15 % 32.73 % 43.25 % 49.79 %
Operating Cash Flow Per Share TTM 0.3 6.58 608.55 - 1.11 -0.71
Free Cash Flow Per Share TTM -0.05 5.1 443.26 - 0.67 -0.71
Cash Per Share TTM 257.58 % 384.5 % 24349.44 % 24.05 % 149.12 % 970.67 %
Operating Cash Flow Sales Ratio TTM 4.66 % 31.71 % 21.01 % - 7.62 % -10.75 %
Free Cash Flow Operating Cash Flow Ratio TTM -17.83 % 77.45 % 72.84 % - 60.43 % 100.44 %
Cash Flow Coverage Ratios TTM 15.3 % 43.63 % 21.32 % - 7.47 % -430.93 %
Price To Free Cash Flows Ratio TTM -103.18 32.07 9.73 - 25.68 -191.12
Price To Operating Cash Flows Ratio TTM 18.02 24.98 7.13 - 15.4 -185.85
Price Cash Flow Ratio TTM 18.02 24.98 7.13 - 15.4 -185.85
Income Statement (TTM)
ACB ZTS TAK HLN TEVA ITCI
Revenue $0.34B $9.26B $4263.76B $11.23B $16.54B $0.68B
Gross Profit $0.19B $6.54B $2832.26B $6.95B $8.06B $0.62B
Gross Profit Ratio 54.65% 70.62% 66.43% 61.85% 48.74% 91.63%
EBITDA $0.05B $3.87B $874.6B $2.51B $0.72B $-0.12B
Net Income $0B $2.49B $144.07B $1.44B $-1.64B $-0.07B
EPS Diluted - 5.47 45.58 0.32 -1.45 -0.72
Balance Sheet (MRQ)
ACB ZTS TAK HLN TEVA ITCI
Long Term Debt $0.08B $5.39B $5029.93B $8.54B $16.3B $0.01B
Total Liabilities $0.24B $9.47B $7834.79B $18.09B $33.61B $0.22B
Total Equity $0.61B $4.77B $7274.01B $16.22B $5.72B $1.15B
Total Investments $0B $0B $445.7B $0.08B $0B $0.69B
Total Debt $0.1B $6.74B $4843.75B $10.1B $18.08B $0.02B
Total Assets $0.85B $14.24B $15108.79B $34.32B $39.33B $1.37B
Cash Flow Statement (TTM)
ACB ZTS TAK HLN TEVA ITCI
Net Income $0.02B $2.5B $144.07B $1.44B $-1.96B $-0.07B
Inventory $-0.02B $-0.04B $-115.74B $0.22B $0.17B $-0.01B
Dividends Paid $0B $-0.79B $-287.19B $-0.57B $0B $0B
Operating Cash Flow $0.02B $2.95B $716.34B $2.3B $1.25B $-0.07B
Capital Expenditure $-0.02B $-0.66B $-480.73B $-0.25B $-0.5B $-0B
Related Stocks
Ticker Name Price
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.43
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 9.42
ALVOW Alvotech 1.7
AMPH Amphastar Pharmaceuticals, Inc. 23.16
AMRX Amneal Pharmaceuticals, Inc. 8.12
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 65.72
APUS Apimeds Pharmaceuticals US, Inc 1.7183
AQST Aquestive Therapeutics, Inc. 3.255
ASRT Assertio Holdings, Inc. 0.6501
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 9.28
AYTU Aytu BioPharma, Inc. 2.07
ETFs With Exposure to ACB
Ticker ETF Name Weight Percentage Price
MJ ETFMG Alternative Harvest ETF 6.25 17.74
ONEQ Fidelity Nasdaq Composite Index ETF 0.01 79.32
PDN Invesco FTSE RAFI Developed Markets ex-U.S. Small-Mid ETF 0.015 38.5922
XCS.TO iShares S&P/TSX Small Cap Index ETF 0.12159 23.16
VALT ETFMG Sit Ultra Short ETF 3.29 48.52
THCX The Cannabis ETF 3.84 16.5963
POTX Global X Cannabis ETF 1.13 5.15
TOKE Cambria Cannabis ETF 2.27 4.47
YOLO AdvisorShares Pure Cannabis ETF 0.85 1.865
DFAI Dimensional International Core Equity Market ETF 0.000538 34.235
SILX ETFMG Prime 2x Daily Junior Silver Miners ETF 2.79 1.75
BAD B.A.D. ETF 2.16 11.91
DFIC Dimensional International Core Equity 2 ETF 0.000345 30.775
DFIS Dimensional International Small Cap ETF 0.002271 29.51
DFSI Dimensional International Sustainability Core 1 ETF 0 38.94
IUSN.DE iShares MSCI World Small Cap UCITS ETF 0.00185 6.868
DFAX Dimensional World ex U.S. Core Equity 2 ETF 0 29.145
CBUG.DE iShares MSCI World Small Cap ESG Enhanced UCITS ETF 0.00038 4.654
DXIV Dimensional ETF Trust 0.00085629 57.43
Unlock